Investigation of Neural Stem Cells in Ischemic Stroke
Public ClinicalTrials.gov record NCT03629275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Placebo-Controlled Study of the Efficacy and Safety of Intracerebral Stem Cells (CTX0E03) in Subjects With Disability Following an Ischemic Stroke
Study identification
- NCT ID
- NCT03629275
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- ReNeuron Limited
- Industry
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Interventions
- CTX0E03 Drug Product and delivery device Combination Product
- Placebo Drug
Combination Product · Drug
Eligibility (public fields only)
- Age range
- 35 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 30, 2018
- Primary completion
- Sep 8, 2020
- Completion
- Mar 1, 2021
- Last update posted
- Aug 12, 2021
2018 – 2021
United States locations
- U.S. sites
- 23
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Arkansas | Little Rock | Arkansas | 72205 | — |
| University of California, Irvine | Irvine | California | 92697 | — |
| University of California, Los Angeles | Los Angeles | California | 90095 | — |
| University of Southern California Neurorestoration Center | Los Angeles | California | 90095 | — |
| Stanford University | Palo Alto | California | 94304 | — |
| University of California, San Diego | San Diego | California | 92093-0706 | — |
| University of Miami | Coral Gables | Florida | 33146 | — |
| University of South Florida | Tampa | Florida | 33606 | — |
| Emory | Atlanta | Georgia | 30322 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Shirley Ryan Ability Lab | Chicago | Illinois | 60611 | — |
| MedStar Health Research Institute | Hyattsville | Maryland | 20782 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| Washington University School of Medicine | St Louis | Missouri | 63130 | — |
| JFK Neuroscience Institute | Edison | New Jersey | 08820 | — |
| Albany Medical College | Albany | New York | 12208 | — |
| Duke University School of Medicine | Durham | North Carolina | 27705 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Chattanooga Center for Neurologic Research | Chattanooga | Tennessee | 37403 | — |
| University of Texas Health Science Center | Houston | Texas | 77030 | — |
| University of Texas Health Science Center | San Antonio | Texas | 78229-3900 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03629275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 12, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03629275 live on ClinicalTrials.gov.